Alex Sapir

Insider Reports History

Location
Durham, NC
Signature
/s/ Greg Tourangeau as attorney-in-fact for Alex Sapir
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alex Sapir:

Company Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. President & Chief Executive Officer, Director Common Stock 193,360 $1,500,474 $7.76 03 Jul 2024 Direct
Fulcrum Therapeutics, Inc. President & Chief Executive Officer, Director Stock option - Right to Buy 582,000 24 Jan 2025 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 3,750 19 May 2023 Direct
PhaseBio Pharmaceuticals Inc Director Restricted Stock Units 0 19 May 2023 Direct

Insider Reports Filed by Alex Sapir

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FULC Fulcrum Therapeutics, Inc. 24 Jan 2025 1 $0 4 President & Chief Executive Officer, Director 28 Jan 2025, 16:15
FULC Fulcrum Therapeutics, Inc. 03 Jul 2024 2 +$490,500 4 President & Chief Executive Officer, Director 08 Jul 2024, 08:00
FULC Fulcrum Therapeutics, Inc. 04 Mar 2024 1 +$492,028 4 President & Chief Executive Officer, Director 05 Mar 2024, 16:15
FULC Fulcrum Therapeutics, Inc. 01 Jul 2023 0 $0 3 President & Chief Executive Officer Exhibit Index: 24.1 Power of Attorney, Director 03 Jul 2023, 16:16
PHASQ PhaseBio Pharmaceuticals Inc 19 May 2023 2 $0 4 Director 19 May 2023, 16:17
PHASQ PhaseBio Pharmaceuticals Inc 19 May 2022 2 $0 4 Director 20 May 2022, 16:45
PHASQ PhaseBio Pharmaceuticals Inc 03 Jun 2021 1 $0 4 Director 04 Jun 2021, 18:14